According to the latest research by Persistence Market Research, the Urea Breath Test Systems market is set to witness a growth of 5% during 2021-2031. Demand for Urea Breath Test Systems expects to witness steady recovery in the short-term, with an optimistic growth outlook in the long run. The growing advancement for the Urea Breath Test Systems market industry will offer lucrative opportunities in near future.


The urea breath test is a test for diagnosing the presence of a bacterium, Helicobacter pylori (H. pylori) infection in the stomach. H. pylori cause inflammation, ulcers, and atrophy of the stomach. The test also may be used to demonstrate that H. pylori have been eliminated by treatment with antibiotics.

The urea breath test is largely adopted for its non-invasive, fast, and most accurate results to detect the presence of active H. pylori infection. According to a study, about 50% of the world’s population is infected with H. pylori. Humans are the principal reservoir. H. pylori are considered to be contagious and passed from person to person by – saliva, dirty waterborne, and poor hygiene practices.

The prevalence of H. pylori infection varies widely by geographic area, age, race, and ethnicity. This finding suggests that poor hygiene and crowded conditions may facilitate the transmission of infection. H. pylori are found in 50-80% of patients with gastric ulcers and 90% of patients with duodenal ulcers.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32645

An estimated one in six individuals infected with H. pylori is expected to eventually develop peptic ulcer disease. This huge number of H. pylori infections will lead to the growth of the urea breath test systems market. H. pylori have been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies.

It is studied that approximately 89% of all gastric cancers are attributed to H. pylori infection and the eradication of this infection will reduce gastric cancer incidence.

Many testing systems and diagnostic methods have been developed over the past decade to detect H. pylori infection among which some were invasive such as rapid urease test, histology, culture, and polymerase chain reaction because they were necessarily performed without endoscopy, and others non-invasive such as serology, urea breath test, antigen determination on feces.

Among these, the urea breath test systems are being increasingly used both in pretreatment and post-treatment phases. There have been subsequent treatment is rising among healthcare professionals. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA) are anticipated to leverage market prospects.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32645

North America held the majority of the revenue share of the global market in 2020. About 30 to 40% of people in the United States get an H. pylori infection. Most people get it as a child. According to a study, in the United States, about four million people have active peptic ulcers and about 350,000 new cases are diagnosed each year.

Four times as many duodenal ulcers as gastric ulcers are diagnosed. Approximately 3000 deaths per year in the United States are due to duodenal ulcers and 3000 to gastric ulcers. This huge number of peptic and gastric ulcers can lead to a large market in North America. In addition, favorable government initiatives, high healthcare expenditure, and technological advancements are the main factors positively impacting urea breath test systems’ regional market growth.

It is studied that H. pylori spread through inadequate sanitation practices, low social class, and crowded or high-density living conditions seem to be related to a higher prevalence of H. pylori infection. Thus developing countries have a high prevalence of H. pylori infection. There are many developing countries in the Asian region and besides high population.

Countries like China and India are highly populated countries with a high prevalence of H. pylori infection and a high incidence of gastro duodenal diseases, with a prevalence of 73.4% and 80% respectively. India has a greater rural area which leads to a prevalence of more than 80%. This massive number of H. pylori infections in the developing countries of Asia will lead to high growth of the market over forecast years.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32645

Some of the key players of Urea Breath Test Systems include,

• Sercon Ltd
• Shenzhen Zhonghe Headway Bio-Sci & Tech Co Ltd.
• Exalenz Bioscience Ltd.
• Beijing Richen-Force Science & Technology Co Ltd
• Kibion AB
• AdvaCare Pharma
• Kizlon Inc.
• Meridian Bioscience Inc.
• Others.

Key Segments

By Product Type

• Urea Breath Test Kits
• Urea Breath Test Analyzer

By End User

• Hospitals
• Specialized Clinics
• Laboratories
• Others

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com